Tokyo -- Kaneka Corporation will appeal a September 2, 2026 ruling by the U.S. District Court for the Eastern District of New York that invalidated its U.S. Patent No. 7,829,080 covering reduced coenzyme Q10, known as ubiquinol.

Kansas City, Mo. – September 12, 2026 -- Google DeepMind has released AlphaGenome Atlas, a one-petabyte AI resource containing molecular-effect predictions for more than 9 billion possible single-letter DNA changes across the human genome, giving researchers browser-based access to the largest catalogue of its kind without writing code.

Cambridge, Massachusetts – September 12, 2026 -- Frost & Sullivan has named ZAGENO its 2026 North America Life Sciences E-Commerce Company of the Year, citing the platform's shift from online marketplace to full procurement orchestration infrastructure for research organizations.

Carlsbad, Calif. – September 12, 2026 -- Tyra Biosciences, Inc. (Nasdaq: TYRA) will hold a virtual fireside chat and one-on-one investor meetings at the Cantor Global Healthcare Conference 2026 on Wednesday, September 9, 2026 at 1:00 PM ET.

Clinical-stage biotech to address investors from New York event

The presentation, though based in New York, NY, will be conducted virtually, with a live webcast accessible via the "For Investors" section of Tyra's website. A replay will be made available following the session.

New York – September 12, 2026 -- Rosen Law Firm has filed a securities class action against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) covering purchasers of the company's securities between December 29, 2025 and June 29, 2026.

Cleveland – September 12, 2026 -- The Austin Company and its affiliate Austin Consulting will exhibit at the 2026 ISPE Annual Meeting and Expo, running October 18-21 at the Gaylord National Resort and Convention Center in National Harbor, Maryland.

Shanghai – September 12, 2026 -- CorrectSequence Therapeutics (Correctseq) reported that its transformer Base Editor (tBE) therapy CS-101/CS-206 delivered durable clinical remission in patients with sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) across four distinct genetic backgrounds, according to a peer-reviewed study published in Cell Stem Cell on September 7, 2026.

Sugar Land, Texas – September 12, 2026 -- QuVa Pharma, Inc. has acquired a range of essential medications from Central Admixture Pharmacy Services, Inc. (CAPS) after CAPS decided to exit the 503B sterile compounding business.

Shanghai – September 11, 2026 -- Natural Field has expanded its NF TriSolve® nutraceutical solutions platform into the sleep wellness category with the launch of NF TriSolve® SleepRestore Complex, targeting a growing segment of the global nutrition market.

Salt Lake City – September 11, 2026 -- A decade-long study by ARUP Laboratories found that 50% of pregnancies with atypical prenatal cell-free DNA (cfDNA) screening results carried at least one clinically significant abnormality confirmed by follow-up testing, reshaping how providers should respond to inconclusive genetic screens.